Biohaven Pharmaceutical Holding Co Ltd. (28) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Membership Interest Purchase Agreement, dated as of February 24, 2022, by and among Biohaven Therapeutics LTD., Knopp Biosciences LLC, Channel Biosciences, LLC and Biohaven... (Filed With SEC on May 10, 2022)
Amendment No. 4 to Financing Agreement, dated as of December 28, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc., the guarantors... (Filed With SEC on February 25, 2022)
Subscription Agreement, dated November 9, 2021, by and between Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd (Filed With SEC on November 12, 2021)
Underwriting Agreement, dated as of March 15, 2021, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on March 17, 2021)
Equity Distribution Agreement, dated as of December 23, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd. and Goldman Sachs & Co. LLC, Piper Sandler & Co., SVB... (Filed With SEC on December 23, 2020)
Funding Agreement by and (Filed With SEC on November 9, 2020)
Series B Preferred Share Purchase Agreement by and (Filed With SEC on November 9, 2020)
Offer Letter dated April 5, 2017 by and between Biohaven Pharmaceuticals, Inc. and Elyse Stock (Filed With SEC on February 26, 2020)
Amendment No. 3 and Limited Consent to Financing Agreement, dated November 9, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc.,... (Filed With SEC on November 12, 2021)
Underwriting Agreement, dated as of January 28, 2020, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on January 30, 2020)
Underwriting Agreement, dated as of June 18, 2019 by and among the Company and Goldman Sachs & Co. LLC and Piper Jaffray & Co., as Representatives of the several Underwriters... (Filed With SEC on June 21, 2019)
Series A Preferred Share Purchase Agreement, dated as of March 18, 2019 (Filed With SEC on May 8, 2019)